Can zinc be an adjuvant therapy for juvenile onset recurrent respiratory papillomatosis?

International Journal of Pediatric Otorhinolaryngology

Volumn 71, Issue 8, 2007, Pages 1163-1173

  Bitar, Mohamed ^a   Baz, Rami ^a   Fuleihan, Nabil ^a   Muallem, Musa ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Adjuvant therapy; Laryngeal; Papillomas; Treatment; Zinc

Indexed keywords

3 INDOLEMETHANOL; ACICLOVIR; CIDOFOVIR; HSPE7 VACCINE; INTERFERON; MUMPS VACCINE; PHOTOFRIN II; RECOMBINANT ALPHA2B INTERFERON; TETRAKIS(3 HYDROXYPHENYL)CHLORIN; UNCLASSIFIED DRUG; VACCINE; ZINC;

ADJUVANT THERAPY; ALOPECIA; ANOREXIA; BRONCHUS SECRETION; CHILL; CLINICAL TRIAL; DEPRESSION; DIARRHEA; DISEASE SEVERITY; DISORIENTATION; DIZZINESS; DROWSINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG WITHDRAWAL; ERYTHEMA; FATIGUE; FEBRILE CONVULSION; FLU LIKE SYNDROME; FOLLOW UP; GAIT DISORDER; GASTROENTERITIS; GASTROINTESTINAL HEMORRHAGE; HEADACHE; HUMAN; IMMUNOMODULATION; JUVENILE ONSET RECURRENT RESPIRATORY PAPILLOMATOSIS; LETHARGY; LIVER DYSFUNCTION; MALAISE; MYALGIA; NAUSEA; NEPHROTOXICITY; NEUTROPENIA; PAPILLOMATOSIS; PRECORDIAL PAIN; PRIORITY JOURNAL; RASH; RECURRENT DISEASE; RELAPSE; REVIEW; SCAR FORMATION; SEIZURE; SIDE EFFECT; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT OUTCOME; VOMITING; WEIGHT REDUCTION; ZINC DEFICIENCY;

ADOLESCENT; ANTIVIRAL AGENTS; CHEMOTHERAPY, ADJUVANT; CHILD, PRESCHOOL; CYTOSINE; DRUG THERAPY, COMBINATION; HUMANS; LARYNGEAL NEOPLASMS; MALE; PAPILLOMA; PHOSPHONIC ACIDS; ZINC;

EID: 34347366182     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2007.05.008     Document Type: Review

References (57)

1. Kashima H.K., Shah F., Lyles A., Glackin R., Muhammad N., Turner L., et al. A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis. Laryngoscope 102 (1992) 9-13
2. Broyles E.N., and Edwin N. Treatment of laryngeal papilloma in children with estrogenic hormones, preliminary report. Bull. Johns Hopkins Hosp. 66 (1940) 319-322
3. Holinger P.H., Johnston K.C., and Anison G.C. Papilloma of the larynx: a review of 109 cases with a preliminary report of aureomycin therapy. Ann. Otol. Rhinol. Laryngol. 59 (1950) 547-564
4. Hollingsworth J.B., Kohlmoos H.W., and McNaught R.C. Treatment of juvenile papilloma of the larynx with resin of podophyllum; a preliminary report. Arch Otolaryngol. 52 (1950) 82-87
5. Moffitt Jr. O.P. Treatment of laryngeal papillomatosis with bovine wart vaccine: report of cases. Laryngoscope 69 (1959) 1421-1428
6. Shipkowitz N.L., Holper J.C., Worland M.C., and Holinger P.H. Evaluation of an autogenous laryngeal papilloma vaccine. Laryngoscope 77 (1967) 1047-1066
7. Derkay C.S., Malis D.J., Zalzal G., Wiatrak B.J., Kashima H.K., and Coltrera M.D. A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis. Laryngoscope 108 (1998) 935-937
8. Al-Gurairi F.T., Al-Waiz M., and Sharquie K.E. Oral zinc sulphate in the treatment of recalcitrant viral warts: randomized placebo-controlled clinical trial. Br. J. Dermatol. 146 (2002) 423-431
9. Lusk R.P., McCabe B.F., and Mixon J.H. Three-year experience of treating recurrent respiratory papilloma with interferon. Ann. Otol. Rhinol. Laryngol. 96 (1987) 158-162
10. Benjamin B.N., Gatenby P.A., Kitchen R., Harrison H., Cameron K., and Basten A. Alpha-interferon (Wellferon) as an adjunct to standard surgical therapy in the management of recurrent respiratory papillomatosis. Ann. Otol. Rhinol. Laryngol. 97 (1988) 376-380
11. Healy G.B., Gelber R.D., Trowbridge A.L., Grundfast K.M., Ruben R.J., and Price K.N. Treatment of recurrent respiratory papillomatosis with human leukocyte interferon. Results of a multicenter randomized clinical trial. N. Engl. J. Med. 319 (1988) 401-407
12. Kashima H., Leventhal B., Clark K., Cohen S., Dedo H., Donovan D., et al. Interferon alfa-n1 (Wellferon) in juvenile onset recurrent respiratory papillomatosis: results of a randomized study in twelve collaborative institutions. Laryngoscope 98 (1988) 334-340
13. Leventhal B.G., Kashima H.K., Weck P.W., Mounts P., Whisnant J.K., Clark K.L., et al. Randomized surgical adjuvant trial of interferon alfa-n1 in recurrent papillomatosis. Arch. Otolaryngol. Head Neck Surg. 114 (1988) 1163-1169
14. Mullooly V.M., Abramson A.L., Steinberg B.M., and Horowitz M.S. Clinical effects of alpha-interferon dose variation on laryngeal papillomas. Laryngoscope 98 (1988) 1324-1329
15. 2-laser and alfa recombinant interferon treatment in five children with juvenile laryngeal papillomatosis. Acta Clin. Belg. 45 (1990) 158-163
16. Leventhal B.G., Kashima H.K., Mounts P., Thurmond L., Chapman S., Buckley S., et al. Long-term response of recurrent respiratory papillomatosis to treatment with lymphoblastoid interferon alfa-N1. Papilloma Study Group. N. Engl. J. Med. 325 (1991) 613-617
17. Avidano M.A., and Singleton G.T. Adjuvant drug strategies in the treatment of recurrent respiratory papillomatosis. Otolaryngol. Head Neck Surg. 112 (1995) 197-202
18. Deunas L., Alcantud V., Alvarez F., Arteaga J., Benitez A., Bopuza M., et al. Use of interferon-alpha in laryngeal papillomatosis: eight years of the Cuban national programme. J. Laryngol. Otol. 111 (1997) 134-140
19. Nodarse-Cuni H., Iznaga-Marin N., Viera-Alvarez D., Rodriguez-Gomez H., Fernandez-Fernandez H., Blanco-Lopez Y., et al. Interferon alpha-2b as adjuvant treatment of recurrent respiratory papillomatosis in Cuba: National Program (1994-1999 report). J. Laryngol. Otol. 118 (2004) 681-687
20. Gerein V., Rastorguev E., Gerein J., Jecker P., and Pfister H. Use of interferon-alpha in recurrent respiratory papillomatosis: 20-year follow-up. Ann. Otol. Rhinol. Laryngol. 114 (2005) 463-471
21. Snoeck R., Wellens W., Desloovere C., Van Ranst M., Naesens L., De Clercq E., et al. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine]. J. Med. Virol. 54 (1998) 219-225
22. Pransky S.M., Magit A.E., Kearns D.B., Kang D.R., and Duncan N.O. Intralesional cidofovir for recurrent respiratory papillomatosis in children. Arch. Otolaryngol. Head Neck Surg. 125 (1999) 1143-1148
23. Pransky S.M., Brewster D.F., Magit A.E., and Kearns D.B. Clinical update on 10 children treated with intralesional cidofovir injections for severe recurrent respiratory papillomatosis. Arch. Otolaryngol. Head Neck Surg. 126 (2000) 1239-1243
24. El Hakim H., Waddell A.N., and Crysdale W.S. Observations on the early results of treatment of recurrent respiratory papillomatosis using cidofovir. J. Otolaryngol. 31 (2002) 333-335
25. Akst L.M., Lee W., Discolo C., Knott D., Younes A., and Koltai P.J. Stepped-dose protocol of cidofovir therapy in recurrent respiratory papillomatosis in children. Arch. Otolaryngol. Head Neck Surg. 129 (2003) 841-846
26. Chhetri D.K., and Shapiro N.L. A scheduled protocol for the treatment of juvenile recurrent respiratory papillomatosis with intralesional cidofovir. Arch. Otolaryngol. Head Neck Surg. 129 (2003) 1081-1085
27. Milczuk H.A. Intralesional cidofovir for the treatment of severe juvenile recurrent respiratory papillomatosis: long-term results in 4 children. Otolaryngol. Head Neck Surg. 128 (2003) 788-794
28. Naiman A.N., Ceruse P., Coulombeau B., and Froehlich P. Intralesional cidofovir and surgical excision for laryngeal papillomatosis. Laryngoscope 113 (2003) 2174-2181
29. Pransky S.M., Albright J.T., and Magit A.E. Long-term follow-up of pediatric recurrent respiratory papillomatosis managed with intralesional cidofovir. Laryngoscope 113 (2003) 1583-1587
30. Lee A.S., and Rosen C.A. Efficacy of cidofovir injection for the treatment of recurrent respiratory papillomatosis. J. Voice 18 (2004) 551-556
31. Mandell D.L., Arjmand E.M., Kay D.J., Casselbrant M.L., and Rosen C.A. Intralesional cidofovir for pediatric recurrent respiratory papillomatosis. Arch. Otolaryngol. Head Neck Surg. 130 (2004) 1319-1323
32. Peyton Shirley W., and Wiatrak B. Is cidofovir a useful adjunctive therapy for recurrent respiratory papillomatosis in children?. Int. J. Pediatr. Otorhinolaryngol. 68 (2004) 413-418
33. Naiman A.N., Ayari S., Nicollas R., Landry G., Colombeau B., and Froehlich P. Intermediate-term and long-term results after treatment by cidofovir and excision in juvenile laryngeal papillomatosis. Ann. Otol. Rhinol. Laryngol. 115 (2006) 667-672
34. Chung B.J., Akst L.M., and Koltai P. 3.5-Year follow-up of intralesional cidofovir protocol for pediatric recurrent respiratory papillomatosis. Int. J. Pediatr. Otorhinolaryngol. 70 (2006) 1911-1917
35. Pudszuhn A., Welzel C., Bloching M., and Neumann K. Intralesional Cidofovir application in recurrent laryngeal papillomatosis. Eur. Arch. Otorhinolaryngol. 264 (2007) 63-70
36. Lopez Aguado D., Perez Pinero B., Betancor L., Mendez A., and Campos Banales E. Acyclovir in the treatment of laryngeal papillomatosis. Int. J. Pediatr. Otorhinolaryngol. 21 (1991) 269-274
37. Morrison G.A., and Evans J.N. Juvenile respiratory papillomatosis: acyclovir reassessed. Int. J. Pediatr. Otorhinolaryngol. 26 (1993) 193-197
38. Endres D.R., Bauman N.M., Burke D., and Smith R.J. Acyclovir in the treatment of recurrent respiratory papillomatosis. A pilot study. Ann. Otol. Rhinol. Laryngol. 103 (1994) 301-305
39. Kiroglu M., Cetik F., Soylu L., Abedi A., Aydogan B., Akcali C., et al. Acyclovir in the treatment of recurrent respiratory papillomatosis: a preliminary report. Am. J. Otolaryngol. 15 (1994) 212-214
40. Abramson A.L., Shikowitz M.J., Mullooly V.M., Steinberg B.M., Amella C.A., and Rothstein H.R. Clinical effects of photodynamic therapy on recurrent laryngeal papillomas. Arch. Otolaryngol. Head Neck Surg. 118 (1992) 25-29
41. Shikowitz M.J., Abramson A.L., Freeman K., Steinberg B.M., and Nouri M. Efficacy of DHE photodynamic therapy for respiratory papillomatosis: immediate and long-term results. Laryngoscope 108 (1998) 962-967
42. Shikowitz M.J., Abramson A.L., Steinberg B.M., DeVoti J., Bonagura V.R., Mullooly V., et al. Clinical trial of photodynamic therapy with meso-tetra (hydroxyphenyl) chlorin for respiratory papillomatosis. Arch. Otolaryngol. Head Neck Surg. 131 (2005) 99-105
43. Rosen C.A., Woodson G.E., Thompson J.W., Hengesteg A.P., and Bradlow H.L. Preliminary results of the use of indole-3-carbinol for recurrent respiratory papillomatosis. Otolaryngol. Head Neck Surg. 118 (1998) 810-815
44. Rosen C.A., and Bryson P.C. Indole-3-carbinol for recurrent respiratory papillomatosis: long-term results. J. Voice 18 (2004) 248-253
45. Borkowski G., Sommer P., Stark T., Sudhoff H., and Luckhaupt H. Recurrent respiratory papillomatosis associated with gastroesophageal reflux disease in children. Eur. Arch. Otorhinolaryngol. 256 (1999) 370-372
46. McKenna M., and Brodsky L. Extraesophageal acid reflux and recurrent respiratory papilloma in children. Int. J. Pediatr. Otorhinolaryngol. 69 (2005) 597-605
47. Pashley N.R. Can mumps vaccine induce remission in recurrent respiratory papilloma?. Arch. Otolaryngol. Head Neck Surg. 128 (2002) 783-786
48. Derkay C.S., Smith R.J., McClay J., van Burik J.A., Wiatrak B.J., Arnold J., et al. HspE7 treatment of pediatric recurrent respiratory papillomatosis: final results of an open-label trial. Ann. Otol. Rhinol. Laryngol. 114 (2005) 730-737
49. Fraker P.J., King L.E., Laakko T., and Vollmer T.L. The dynamic link between the integrity of the immune system and zinc status. J. Nutr. 130 Suppl. 5 (2000) S1399-S1406
50. Dardenne M. Zinc and immune function. Eur. J. Clin. Nutr. 56 Suppl. 3 (2002) S20-S23
51. Bondestam M., Foucard T., and Gebre-Medhin M. Subclinical trace element deficiency in children with undue susceptibility to infections. Acta Paediatr. Scand. 74 (1985) 515-520
52. Bahl R., Bhandari N., Hambidge K.M., and Bhan M.K. Plasma zinc as a predictor of diarrheal and respiratory morbidity in children in an urban slum setting. Am. J. Clin. Nutr. 68 Suppl. 2 (1998) S414-S417
53. Van Wouwe J.P. Clinical and laboratory assessment of zinc deficiency in Dutch children. Biol. Trace Elem. Res. 49 (1995) 211-225
54. Shankar A.H., and Prasad A.S. Zinc and immune function: the biological basis of altered resistance to infection. Am. J. Clin. Nutr. 68 Suppl. 2 (1998) S447-S463
55. Wellinghausen N. Immunobiology of gestational zinc deficiency. Br. J. Nutr. 85 Suppl. 2 (2001) S81-S86
56. Driessen C., Hirv K., Rink L., and Kirchner H. Induction of cytokines by zinc ions in human peripheral blood mononuclear cells and separated monocytes. Lymphokine Cytokine Res. 13 (1994) 15-20
57. Wellinghausen N., Kirchner H., and Rink L. The immunobiology of zinc. Immunol. Today 18 (1997) 519-521